Leukemia drug-maker fined, shut down
14 December 2007
State-owned pharmaceutical company Shanghai Hualian has been fined the maximum amount under law and forced to shut down for making tainted leukemia drugs that caused partial paralysis in dozens of patients, the Wall Street Journal reported. All sales of the drug were suspended in July by the State Food and Drug Administration (SFDA) which after an investigation described Hualian's actions as a "systematic" cover-up. In September, the SFDA forbade the company to produce the drug altogether. The tainted drugs are thought to have affected over 100 people across China.
Bookmark and Share:
Other Categories
Other news from 14 December 2007
Related Articles
- Leukemia drug-maker fined, shut down
- China recalls suspect leukemia drugs
- Balian talks expansion before market debut
- Chinese stores look to Europe
- Sports shoes maker ready to expand
To receive the best China business news that the market has to offer,
subscribe to the China Economic Review.
subscribe to the China Economic Review.